NO20024210D0 - Virusantigen og vaksine mot ISAV (infeksiöst lakseanemivirus) - Google Patents

Virusantigen og vaksine mot ISAV (infeksiöst lakseanemivirus)

Info

Publication number
NO20024210D0
NO20024210D0 NO20024210A NO20024210A NO20024210D0 NO 20024210 D0 NO20024210 D0 NO 20024210D0 NO 20024210 A NO20024210 A NO 20024210A NO 20024210 A NO20024210 A NO 20024210A NO 20024210 D0 NO20024210 D0 NO 20024210D0
Authority
NO
Norway
Prior art keywords
virus
vaccine against
infectious salmon
salmon anemia
against isav
Prior art date
Application number
NO20024210A
Other languages
English (en)
Other versions
NO20024210L (no
Inventor
William Thomas Melvin
Suzanne Breeman
Marie Beagley Labus
Original Assignee
Univ Aberdeen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0005457A external-priority patent/GB0005457D0/en
Priority claimed from GB0005960A external-priority patent/GB0005960D0/en
Priority claimed from GB0029409A external-priority patent/GB0029409D0/en
Application filed by Univ Aberdeen filed Critical Univ Aberdeen
Publication of NO20024210D0 publication Critical patent/NO20024210D0/no
Publication of NO20024210L publication Critical patent/NO20024210L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
NO20024210A 2000-03-08 2002-09-04 Virusantigen og vaksine mot ISAV (infeksiost lakseanemivirus) NO20024210L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0005457A GB0005457D0 (en) 2000-03-08 2000-03-08 Salmon antigen sequence
GB0005960A GB0005960D0 (en) 2000-03-14 2000-03-14 Salmon antigen sequence
GB0029409A GB0029409D0 (en) 2000-12-01 2000-12-01 Salmon anaemia
PCT/GB2001/001013 WO2001066569A1 (en) 2000-03-08 2001-03-08 Viral antigen and vaccine against isav (infectious salmon anaemia virus)

Publications (2)

Publication Number Publication Date
NO20024210D0 true NO20024210D0 (no) 2002-09-04
NO20024210L NO20024210L (no) 2002-11-06

Family

ID=27255584

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20024210A NO20024210L (no) 2000-03-08 2002-09-04 Virusantigen og vaksine mot ISAV (infeksiost lakseanemivirus)

Country Status (5)

Country Link
EP (1) EP1263781B1 (no)
AU (1) AU4078401A (no)
CA (1) CA2402339C (no)
NO (1) NO20024210L (no)
WO (1) WO2001066569A1 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1637614A3 (en) 1999-08-07 2006-11-29 Novartis AG Nucleic acids and antibodies for detection of ISAV (infectious salmon anaemia virus)
CA2687208C (en) 2006-12-22 2017-02-14 Soluciones Biotecnologicas Innovacion Ltda Process and formulation for immunizing fish in aquaculture systems

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1637614A3 (en) * 1999-08-07 2006-11-29 Novartis AG Nucleic acids and antibodies for detection of ISAV (infectious salmon anaemia virus)
DE60017229D1 (de) * 1999-10-18 2005-02-10 Akzo Nobel Nv DNA kodierend für das Strukturalprotein-1 vom infektiösen Lachs Anämie Virus und ihre Verwendungen

Also Published As

Publication number Publication date
AU4078401A (en) 2001-09-17
CA2402339A1 (en) 2001-09-13
WO2001066569A1 (en) 2001-09-13
EP1263781B1 (en) 2006-11-22
CA2402339C (en) 2010-01-12
NO20024210L (no) 2002-11-06
EP1263781A1 (en) 2002-12-11

Similar Documents

Publication Publication Date Title
LTC1377660I2 (lt) Vakcina nuo Nilo karštligės viruso
NO20031483D0 (no) Vaksine
IS7133A (is) Afleiða beta-amyloid - T-frumu-mótefnavísisbóluefni
CY2007008I1 (el) Εμβολιο ανθρωπινου ιου θηλωματων με αποσυγκροτημενα και επανασυγκροτημενα σωματιδια ομοιαζοντα με αυτα του ιου
NO20024172L (no) Vaksine
IL158428A0 (en) Vaccine composition comprising at least one hiv virus antigen
NO20033882L (no) Vaksine
NO20033829L (no) Virusdrepende preparater
IS5777A (is) Bóluefnisvakið lifrarbólgu B veiruafbrigði og notkun þess
NO20024210D0 (no) Virusantigen og vaksine mot ISAV (infeksiöst lakseanemivirus)
DK1372712T3 (da) Vaccine mod equint herpesvirus
ATE505482T1 (de) Impfstoff gegen infektiöses lachsanämievirus
DK1280551T3 (da) Vacciner mod HIV-infektion
NO992608L (no) Vaksine mot ILA-virus
EP1268750A4 (en) IMPROVED METHODS FOR ISOLATING, IDENTIFYING, QUANTIFYING AND REPRODUCING THE INFECTIOUS ANEMYVIRUS OF CHICKENS AND HIGH-TEMPERED VITAMIN
PL364832A1 (en) Detection of infectious agents using antigen mimics
NO20033934L (no) Naturlig antistoff aktiv mot HIV-viruset
AU2002350549A1 (en) Infectious salmon anaemia virus vaccine
AU2003240866A8 (en) Antibodies, peptides and vaccines against hiv-1 virus
NO20012126D0 (no) HIV-vaksine
GB0023445D0 (en) Attenuated virus vaccine
IL136859A0 (en) Recombinant vaccines against infectious bursal disease virus
IL179422A0 (en) Recombinant vaccines against infectious bursal disease virus

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application